Biomarkers /
CSF3R
Back to Biomarkers List
Overview
Colony stimulating factor 3 receptor (CSF3R) is a gene that encodes the receptor associated with colony stimulating factor 3, which is a member of the family of cytokine receptors. Missense mutations, nonsense mutations, silent mutations, and frameshift mutations are observed in cancers such as colorectal cancer, leukemias, lung cancer, skin cancer, and stomach cancer.
CSF3R is altered in 1.54% of all cancers with colon adenocarcinoma, lung adenocarcinoma, cutaneous melanoma, endometrial endometrioid adenocarcinoma, and breast invasive ductal carcinoma having the greatest prevalence of alterations [3].
The most common alterations in CSF3R are CSF3R Mutation (1.27%), CSF3R Exon 17 Mutation (0.31%), CSF3R Exon 14 Mutation (0.11%), CSF3R Amplification (0.13%), and CSF3R Exon 15 Mutation (0.04%) [3].
Clinical Trials
Significance of CSF3R in Diseases
References
1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.
